UK-headquartered immunodiagnostics specialist Oxford Immunotec Global plc's share value slipped by $1.31 to...
Up To Date
Latest News
German CellAct GmbH has cashed in US$250m (€212m) from Mundipharma in a licence deal for CAP7.1, a Phase II...
Germany is the first country that has granted full approval to Adrenomed to conduct a Phase II study with the...
Caisse de dépôt et placement du Québec (CDPQ) is set to acquire a minority stake in diagnostic electrophoresis...
Serial drug licensee Roivant Sciences GmbH (Basel) has cashed in US$1.1bn (€937m) in an equity financing led...
The Leukemia & Lymphoma Society (LLS) and Polish drug developer Selvita SA have entered a partnership to...